Article Text

PDF

Comment on ‘Unanticipated bleeding with the etonogestrel implant: advice and therapeutic interventions’: author's response
  1. Jane Dickson, MA, MFSRH
  1. Consultant in Sexual and Reproductive Healthcare, Oxleas NHS Foundation Trust, London, UK; jane.dickson{at}nhs.net

Statistics from Altmetric.com

I would like to thank Drs Ronghe and Welsh for their response to our commentary1 and for sharing their audit results.2 I note that when they prepared their training and interventions, they advised either use of the combined oral contraceptive pill (COC) or the progestogen-only pill (POP) for the management of troublesome bleeding. Both Faculty of Sexual & Reproductive Healthcare guidance3 and our commentary1 cite the use of the COC but not the POP as the main intervention for implant bleeding. There is no evidence that the POP used in this manner is effective, even though anecdotally it is occasionally used. It is interesting that there was no improvement in implant retention in Drs Ronghe and Welsh's follow-up audit. I wonder if these results could be analysed to determine if it was those women given the POP who did not improve and whether or not there was any difference in the results depending upon which treatment was used.

References

View Abstract

Footnotes

  • Competing interests None.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Linked Articles